FAQ

LIQUID LIPO SHOT™

Experience the Full Spectrum of Benefits: GLP-1 Medications for Diabetes,
Weight, and Heart Health. These medications, mirroring the natural hormone
GLP-1, not only manage blood sugar but also aid weight loss, promote heart
health, preserve beta-cell function, and lower the risk of hypoglycemia.

SEMAGLUTIDE

Semaglutide, a potent glucagon-like peptide-1 (GLP-1) receptor agonist initially prescribed for type 2 diabetes, now stands as a groundbreaking treatment addressing both diabetes and obesity. Administered weekly via injections, it not only effectively regulates blood sugar levels but also induces significant weight loss. This multifaceted approach offers a comprehensive solution for individuals grappling with the challenges of type 2 diabetes and obesity, making semaglutide a remarkable and versatile therapeutic option at the intersection of metabolic health and weight management.

How does your company ensure the quality and purity of GLP-1 products during the manufacturing process?

Our injectables, including GLP-1 products, undergo rigorous manufacturing processes and quality assurance measures. We operate in state-of-the-art facilities covering a combined 60,000 Sq Ft, exceeding basic standard requirements. Our dedicated team of over 400 staff includes microbiologists, pharmacists, clinical pharmacists, a retired FDA manufacturing Inspector (our
quality auditor), cGMP talent and supporting staff.

Can you provide information about the testing and quality control procedures for GLP-1 products, including potency and analytical parameters?

Each batch of our products undergoes thorough testing for sterility and potency. We also conduct quality audits on our FDA
registered API (Active Pharmaceutical Ingredient) vendors to ensure the quality of the ingredients used in our products.

Are you using the salt form (sodium or acetate) of Semaglutide for compounding?

No. Our Semaglutide is of pure base form.

How does LIQUID LIPO SHOT™ address concerns from patients who may not be achieving the expected results with GLP-1?

We understand the frustration of patients not achieving expected results. The reasons for lack of response could include dosing titration, injection technique, insulin resistance, duration of use and other variables. We emphasize the importance of discussing expectations with healthcare providers and are committed to collaborating with them to address concerns.

Can you elaborate on the duration of gastric side effects?

Glp-1 medications like Semaglutide may initially cause gastric side effects such as nausea and heartburn. However, these side effects tend to diminish over time as dosing stabilizes. Patients should be aware that increasing dosing during titration
may temporarily bring back side effects, but they typically lessen or disappear as the body adjusts. Side effects may be managed by slowing the titration schedule, decreasing the dosage, and/or using anti-emetic medications such as Ondansetron.

What advice do you have for patients using GLP-1 regarding injection technique and the administration schedule
for optimal results?

It's essential to ensure correct dosing titration, meticulous injection technique, and using the right needle length. Insulin-resistant patients may need to balance sugar levels first. Many patients experience greater weight loss as the therapy progresses versus the expected immediate results. Staying consistent with the administration schedule, injecting on the same day and time every week, is recommended for optimal results. We stress the importance of maintaining good hydration during medication therapy.